Sight Sciences

Update in progress

SGHT (NasdaqGS)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

Sight Sciences, Inc. is an ophthalmic medical device company that develops and commercializes surgical and nonsurgical technologies for eye diseases in the United States. It operates in Surgical Glaucoma and Dry Eye. Its products include the OMNI surgical system (OMNI Ergo for canal and trabecular meshwork treatment; OMNI EDGE, a minimally invasive glaucoma technique), SION, and TearCare for evaporative dry eye related to meibomian gland disease. It serves hospitals, clinics, and eye care professionals.

Company score

Sentiment: 0.42; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.08; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.15; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.06; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.24; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive